	Chinese Society of Clinical Oncology breast cancer expert consensus on the diagnosis and treatment of breast cancer brain metastasis (2025). Transl Breast Cancer Res Wang T, Chen J, Yang J, Fu M, Hua W, Jia W, Liu Y, Wang B, Yan M, Hao C, Chen J, Ou D, Song E, Jiang T, Mao Y, Jiang Z, CSCO Expert Panel of Breast Cancer, Experts of the Neurological Tumor Specialist Committee of the Chinese Society of Clinical Oncology (CSCO). PMID: 42170569 [PubMed]
	Resting-State Coactivation Patterns of Language Reorganization in Brain Tumors. Neural Plast Napolitano A, Spitoni L, Jenabi M, Peck KK, Holodny AI, Moliterno J, Constable T, Pasquini L. PMID: 42169456 [PubMed - indexed for MEDLINE]
	A multi-level attention CNN-transformer based framework for the detection of brain tumor using regional dual-score explainability. Sci Rep Kaprekar A, Gudigar A, Raghavendra U, Inamdar MA, Salvi M, Priyanka, Acharya UR. PMID: 42168501 [PubMed - as supplied by publisher]
	Health-related quality-of-life of WHO grade 4 astrocytoma patients receiving alternating electrical field therapy: a prospective real-world multi-centre study. J Neurooncol Wong DKK, Pu JKS, Li LF, Hui VKH, Suen KKF, Lau ACK, Chan DTM, Lee MWY, Chan TKT, Ho JMK, Cheung KM, Tse TPK, Lau SSN, Chow JSW, See MKW, Ko NMW, Loong HHF, Leung DKC, El-Helali A, Lam TC, Cheung FC, Poon WS, Woo PYM. PMID: 42168436 [PubMed - indexed for MEDLINE]
	Adenosine Signaling in Primary and Metastatic Brain Tumors: Immune Suppression, Tumor Progression, and Therapeutic Opportunities. Mol Neurobiol de Oliveira Lima T, Soares AA, Böhm BR, Teixeira BM, da Costa LCT, Pretto KP, de Souza JVG, da Cunha MLV, Lameu C, Boison D, de Resende eSilva DT. PMID: 42168394 [PubMed - indexed for MEDLINE]
	An explainable multi-stage framework for brain tumor classification using hybrid feature fusion and EfficientNetB5 model. Sci Rep Qureshi I, Zaheer Sajid M, Youssef A, Fareed Hamid M, Alobaidan Y, Abbas Q, Jan R, Ibrahim MEA. PMID: 42168316 [PubMed - as supplied by publisher]
	Comprehensive quantum chemical analysis, vibrational spectroscopy, molecular docking, ADMET, and in vitro validation studies of hydroxychloroquine-MRGPRX2 complex in IDH-wildtype glioblastoma. PLoS One Demirag AD, Aksoy RA, Akman G, Kaya V, Yildirim M. PMID: 42166475 [PubMed - indexed for MEDLINE]
	Percentage signal recovery plus relative cerebral blood volume: a practical dual-parameter strategy for differentiating post-stereotactic radiosurgery tumour progression from radiation necrosis in brain metastases. Insights Imaging Sawlani V, Mei N, Flintham R, Meade S, Benghiat H, Nagaraju S, Ughratdar I, Davies N, Pohl U, Sanghera P, Wykes V. PMID: 42166098 [PubMed]
	Image-Guided Brain Tumor Surgery. Recent Results Cancer Res Schipmann S, Schwake M, Stummer W. PMID: 42165835 [PubMed - indexed for MEDLINE]
	Biomarkers for predicting immunotherapy response and resistance in glioblastoma. Front Immunol Kim S, Abikenari M, Bergsneider B, Kim LH, Lim M. PMID: 42164498 [PubMed - indexed for MEDLINE]
	Predictive value of systemic immune-inflammatory markers for lung cancer-associated cerebral infarction: a retrospective cohort study. Am J Cancer Res Zhu D, Wang H, Yan Z, Zhao J, Sun Y, Zhu D, Zhang P. PMID: 42163874 [PubMed]
	Delayed presentation of a pediatric giant traumatic pseudoaneurysm mimicking a brain tumor: a case report. Childs Nerv Syst Erol A, Karagöz C, Ay LA, Ç, Bolat E. PMID: 42162442 [PubMed - indexed for MEDLINE]
	Cytokine network in immunosuppression and tumor development in glioblastoma. Int Rev Cell Mol Biol Granda-Díaz R, Martínez-Pérez A, Aguilar-García C, Sordo-Bahamonde C. PMID: 42161467 [PubMed - indexed for MEDLINE]
	Global Disparities in Paediatric Brain Tumour Surgery. J Pak Med Assoc Javed J, Nisar F, Shamim MS. PMID: 42160571 [PubMed - indexed for MEDLINE]
	MGMT promoter methylation status for glioblastoma: defining the clinically relevant cut-off value for pyrosequencing. J Neurooncol Skarin N, Hallbeck M, Werlenius K, Rohan Z, Sandström M, Turanyi E, Löfgren D, Johansson H, Strandéus M, Tavelin B, Malmström A. PMID: 42159893 [PubMed - indexed for MEDLINE]
	Treatment patterns and outcomes in high-risk WHO grade 2 diffuse glioma: a multicentre retrospective cohort study. J Neurooncol Jia JL, Alshamsan B, Andronic C, Fazzari F, Shah H, Leigh J, Chan A, Machado M, Lim Fat MJ, Baer K, MacDonald M, Wang X, Mason W, Chahal M, Hussain M, Urgoiti GR, Ng TL. PMID: 42159820 [PubMed - indexed for MEDLINE]
	Retracted: Diagnostic Discrepancies Between Intraoperative Frozen Section and Permanent Histopathological Diagnosis of Brain Tumors. Turk Patoloji Derg Kurdi M, Baeesa S, Maghrabi Y, Bardeesi A, Saeedi R, Al-Sinani T, Samkari A, Lary A, Hakamy S. PMID: 42159419 [PubMed - in process]
	Cost-effectiveness of vorasidenib in treatment of isocitrate dehydrogenase-mutated low-grade glioma. Cancer Kessel AC, Kim H, Brown PD, Lehrer EJ, Laack NN, Mahajan A, Yan E, Schultz SE, Kizilbash S, Neth B, Sener U, Waddle M, Breen WG, Kowalchuk RO. PMID: 42159181 [PubMed - indexed for MEDLINE]
	Correction to "Hybrid CNN-GCN framework for brain tumor MRI classification: A graph-based approach to smart healthcare diagnostics". J Appl Clin Med Phys PMID: 42159089 [PubMed - in process]
	Current Status and Evolution of Immunotherapy in Glioma Management. Int J Med Sci Liu J, Yang G, Cao Z, Qin H, Zhu M, Zou C, Liu X, He Y, Gu J. PMID: 42158823 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 58765

Page 1 of 2939



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy